MAXALT
These highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT (rizatriptan benzoate) tablets, for oral useMAXALT-MLT (rizatriptan benzoate) orally disintegrating tabletsInitial U.S. Approval: 1998
3756d8e3-7e89-46c7-8723-6fea65363913
HUMAN PRESCRIPTION DRUG LABEL
Mar 14, 2012
Physicians Total Care, Inc.
DUNS: 194123980
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
rizatriptan benzoate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
rizatriptan benzoate
Product Details
FDA regulatory identification and product classification information